Harvard Bioscience Files 8-K/A Amendment on Delisting Concerns
Ticker: HBIO · Form: 8-K/A · Filed: Jun 27, 2025 · CIK: 1123494
| Field | Detail |
|---|---|
| Company | Harvard Bioscience Inc (HBIO) |
| Form Type | 8-K/A |
| Filed Date | Jun 27, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: delisting, listing-standards, amendment
TL;DR
Harvard Bioscience filed an 8-K/A amendment about delisting rules - stock might be in trouble.
AI Summary
Harvard Bioscience, Inc. filed an amendment (8-K/A) on June 27, 2025, regarding a notice of delisting or failure to satisfy continued listing rules, originally reported on June 18, 2025. The filing includes financial statements and exhibits.
Why It Matters
This amendment signals potential issues with Harvard Bioscience's continued listing on an exchange, which could impact investor confidence and stock liquidity.
Risk Assessment
Risk Level: medium — Filings related to delisting or failure to meet listing standards indicate potential financial or operational distress for the company.
Key Players & Entities
- Harvard Bioscience, Inc. (company) — Registrant
- June 18, 2025 (date) — Earliest event reported
- June 27, 2025 (date) — Filing date
- 84 October Hill Road, Holliston, MA 01746 (address) — Principal Executive Offices
FAQ
What specific listing rule or standard did Harvard Bioscience, Inc. fail to satisfy, as indicated by the 8-K/A filing?
The filing is an amendment to a previous report concerning a 'Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard,' but the specific rule or standard is not detailed in the provided text.
When was the original event that triggered the notice of delisting or failure to satisfy listing rules?
The earliest event reported, which is the subject of this amendment, occurred on June 18, 2025.
What is the purpose of filing an 8-K/A form in this context?
An 8-K/A form is an amendment to a previously filed Current Report on Form 8-K, used to correct or supplement information previously reported.
What are the principal executive offices of Harvard Bioscience, Inc.?
The principal executive offices are located at 84 October Hill Road, Holliston, MA 01746.
What is the SIC code for Harvard Bioscience, Inc.?
The Standard Industrial Classification (SIC) code for Harvard Bioscience, Inc. is 3826, which corresponds to Laboratory Analytical Instruments.
Filing Details
This Form 8-K/A (Form 8-K/A) was filed with the SEC on June 27, 2025 regarding HARVARD BIOSCIENCE INC (HBIO).